Article ID Journal Published Year Pages File Type
5697610 Cancer Treatment Reviews 2017 44 Pages PDF
Abstract
In HER2-positive breast cancer, high baseline TIL are associated with increased pCR probability irrespective of neoadjuvant anti-HER2 agent(s) and chemotherapy regimens used.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
Authors
, , , , , , , , , , , ,